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Abstract 
Objectives: Low-density granulocytes (LDGs) are a distinct subset of pro-inflammatory 
and vasculopathic neutrophils expanded in systemic lupus erythematosus (SLE). 
Neutrophil trafficking and immune function are intimately linked to cellular biophysical 
properties. This study used proteomic, biomechanical, and functional analyses to further 
define neutrophil heterogeneity in the context of SLE.  
Methods: Proteomic/phosphoproteomic analyses were performed in healthy control 
(HC) normal density neutrophils (NDNs), SLE NDNs and autologous SLE LDGs.  The 
biophysical properties of these neutrophil subsets were analyzed by real-time 
deformability cytometry (RT-DC) and lattice light-sheet microscopy. A two-dimensional 
endothelial flow system and a three-dimensional microfluidic microvasculature mimetic 
(MMM) were used to decouple the contributions of cell surface mediators and 
biophysical properties to neutrophil trafficking, respectively. 
Results: Proteomic and phosphoproteomic differences were detected between HC and 
SLE neutrophils and between SLE NDNs and LDGs. Increased abundance of type 1 
interferon-regulated proteins and differential phosphorylation of proteins associated with 
cytoskeletal organization were identified in SLE LDGs relative to SLE NDNs. The cell 
surface of SLE LDGs was rougher than in SLE and HC NDNs, suggesting membrane 
perturbances. While SLE LDGs did not display increased binding to endothelial cells in 
the two-dimensional assay, they were increasingly retained/trapped in the narrow 
channels of the lung MMM.  
Conclusions: Modulation of the neutrophil proteome and distinct changes in biophysical 
properties are observed alongside differences in neutrophil trafficking. SLE LDGs may 
be increasingly retained in microvasculature networks, which has important pathogenic 
implications in the context of lupus organ damage and small vessel vasculopathy. 
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Introduction 
 
Neutrophil dysregulation may play critical roles in SLE pathogenesis1. Enhanced release 
of neutrophil extracellular traps (NETs)- the externalization of oxidized nucleic acids and 
granule proteins- promotes immune dysregulation, vasculopathy and organ damage 
associated with SLE2-5.  
We previously identified a subset of SLE proinflammatory neutrophils (low density 
granulocytes, LDGs), purified from the peripheral blood mononuclear cell (PBMC) layer 
6. In contrast to normal dense neutrophils (NDNs), LDGs spontaneously form 
proinflammatory NETs 7 8 induce endothelial damage 6, and associate with in vivo 
vascular inflammation, coronary atherosclerosis 5 9-11, and T cell activation 12, suggesting  
they play important roles in SLE pathogenesis. 
 
Previous LDG studies focused on transcriptomic analysis, with little known about 
proteome modulation and protein function 8 9 13-16.  Proteomic analyses comparing SLE 
LDGs to SLE and healthy control (HC) NDNs, identified differential phosphorylation of 
proteins associated with cytoskeletal organization. Using real-time deformability 
cytometry (RT-DC) and a polydimethylsiloxane (PDMS) device mimicking neutrophil 
trafficking through the pulmonary microvasculature, we determined SLE LDGs are 
biophysically distinct from other neutrophil subsets, which may affect their ability to traffic 
through small blood vessels. 
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Methods 
See online supplementary material.  
 
Results 
 
Differential protein profiles of lupus and HC neutrophils 
 
Proteomic/phosphoproteomic analyses were performed in SLE LDGs and NDNs, 
and HC NDNs (n=5/group; Supplementary Tables 1, 2). As controls, HC NDNs were 
also analyzed following priming with N-formylmethionine leucyl-phenylalanine (fMLF), 
given that priming decreases HC NDN density 17. Neutrophil preparations used identical 
protocols optimized to minimize biophysical or functional disruption of cells from their 
unstimulated state in whole blood (Supplementary Figure 1).  
  
Neutrophil mass spectrometry analysis identified 4109 proteins (Figure 1A), of which 601 
(14.6%) and 685 (16.6%) were identified only in HC or SLE neutrophils, respectively 
(Supplementary Figure 2A-B). This is comparable to the most robust neutrophil 
proteomic analysis previously reported 18. Results were aligned with SLE LDG, NDN, 
and HC NDN transcriptomics (GEO GSE139358) 
16
 to identify proteins not present at the 
mRNA level that may be of exogenous source (Supplementary Figure 3). SLE LDGs and 
NDNs showed complete proteome overlap, albeit with considerable variation in protein 
abundance. Indeed, 9.4% of proteins expressed by SLE neutrophils were differentially 
abundant in SLE LDGs vs NDNs, with 270 more abundant and 60 less abundant (ratio 
cut-off >1.5 or <0.5 in at least 4/5 matched samples; Figure 1C). Of the 2823 proteins 
common to both SLE and HC NDNs, 304 (10.7%) showed differential abundance. 
FMLF-primed and unstimulated HC NDNs showed complete proteome overlap with little 
variation in protein abundance, except for decreased abundance of L-selectin in primed 
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HC NDNs, suggesting protein shedding from in vitro activation 19 (Supplementary Figure 
2D-H). Overall, many proteins were uniquely present in either HC or SLE neutrophils 
and protein abundances varied between subsets, indicating neutrophil proteome 
heterogeneity. 
 
We identified 875 proteins phosphorylated on serine, threonine, and/or tyrosine residues 
in neutrophils (Figure 1B). Some proteins were phosphorylated at multiple sites 
(Supplementary Table 3). Of these phosphoproteins, 48 (5.4%) and 366 (41.8%) were 
only identified in HC NDNs and SLE neutrophils, respectively. The same 
phosphoproteins were identified in HC unstimulated and fMLF-primed NDNs, and one 
phosphoprotein was uniquely identified in SLE LDGs (round spermatid basic protein 1-
like protein, pRSBN1L; Supplementary Figure 2C). When comparing SLE LDGs and 
NDNs, 95 phosphoproteins (11.5%) were differentially abundant, with 11 less and 84 
more abundant in SLE LDGs (Figure 1D). Of the 509 phosphoproteins co-expressed in 
fMLF-primed and unstimulated HC NDNs, 167 (32.8%) were differentially abundant 
(Supplementary Figure 2E). Of the 460 phosphoproteins common to all neutrophils, 100 
(21.7%) were differentially abundant between HC and SLE NDNs (Supplementary 
Figure 2G). These data support neutrophil phosphoproteome heterogeneity. 
 
 
 
The LDG proteome displays a distinct profile 
 
Using ShinyGO 20 and MetaScape 21, we mapped proteins differentially abundant 
in at least 4/5 samples to known gene-ontology biological processes.  Proteins more 
abundant in SLE NDNs relative to HC NDNs mapped to neutrophil activation networks, 
including proteins facilitating migration to inflammatory sites and release from bone 
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marrow 22-24. Some proteins associated with neutrophil activation were most abundant in 
SLE LDGs (Figure 1E-F).  
 
SLE subjects express elevated type 1 IFN-stimulated genes (ISGs) in various organs 
and cells, including NDNs and LDGs 16 25. While ISG-encoded proteins were not 
uniformly upregulated in SLE NDNs vs HC NDNs, many were upregulated in SLE LDGs 
relative to SLE or HC NDNs (Figure 1G). ISG transcription is mediated by 
phosphorylation of signal transducer and activator of transcription (STAT) molecules 26 
but we did not detect phospho-STATs, possibly because pTyr residues are less 
abundant than pSer 27. Limited LDG numbers prevented immunoprecipitation of pTyr 
residues alongside phosphopeptide enrichment. Collectively, the SLE neutrophil 
proteome suggests an activated status, while the IFN-associated protein signature is 
distinct to SLE LDGs. 
 
Neutrophil priming/activation facilitates interactions with the endothelium 28. There were 
no differences in adhesion molecule or integrin expression among neutrophil subsets. 
However, phosphoproteins regulating neutrophil-endothelial interactions were more 
abundant in fMLF-primed HC NDNs than other neutrophil subsets (Figures 1H-I).  This 
suggests differences between SLE LDGs/NDNs and fMLF-primed HC NDNs. 
 
Proteins with differential phosphorylation in SLE NDNs vs HC NDNs were associated 
with organelle organization and actin cytoskeletal organization, including phospho-
coronin 1A (pCORO1A) and phospho-heat shock protein 90AA1 (pHSP90AA1) 
(Supplementary Figure 2H). Some proteins less abundant in SLE LDGs vs SLE NDNs 
associated with neutrophil degranulation but key granule proteins, including 
myeloperoxidase and cathepsin-G, were not decreased (Figures 2A-B). Rather, lower 
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abundance of membrane proteins, particularly ficolin-1-rich granule membrane proteins, 
accounted for downregulated degranulation-associated networks in SLE LDGs. 
Differences in degranulation capabilities did not explain changes in the neutrophil 
proteome between neutrophil subsets. 
 
Abundant proteins in SLE LDGs vs SLE NDNs clustered in neutrophil activation, 
coagulation, platelet, and intracellular trafficking networks (Figure 2C). The SLE 
biological network (False Discovery Rate (FDR) = 10-11.119) was upregulated in SLE 
LDGs vs autologous NDNs, primarily driven by complement proteins (Figure 2D). 
Immunoglobin chains and apolipoproteins were more abundant in SLE LDGs vs other 
neutrophils. Differential phosphorylation in SLE LDGs vs NDNs also associated with 
neutrophil activation and intracellular trafficking. In addition, SLE LDGs expressed higher 
abundances of ribosomal proteins (Figures 2E-G).  
 
SLE LDGs are a heterogeneous group comprising of CD10- (immature, less abundant) 
and CD10+ (intermediate-mature, most abundant) subsets. CD10- LDGs have decreased 
CEBPD and SPI1 transcripts relative to SLE NDNs and CD10+ LDGs 16. Proteomic 
analysis was completed on unfractionated SLE LDGs and displayed similar SPI1 protein 
abundance across neutrophil subsets. CEBPD was not identified in HC NDNs but was 
similar in SLE LDGs and NDNs (Figure 2H). Most  SLE LDGs had multi-lobulated nuclei 
(Supplementary Figure 1C), confirming  intermediate-mature cells represent the most 
abundant LDG subset 16.  
 
SLE LDGs and NDNs differ in expression of cytoskeleton-associated proteins  
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Consistent with evidence that cytoskeleton-associated transcriptional networks 
are enhanced in SLE LDGs 8, we found upregulation at the protein level when compared 
to autologous NDNs (Figure 3A). Many proteins differentially expressed and/or 
phosphorylated in LDGs regulate intracellular trafficking (Figure 3B-C)29-33. In addition, 
we assessed modulation of the HC NDN phosphoproteome by fMLF 17 34 35. Many 
proteins differentially phosphorylated in fMLF-primed HC NDNs were associated with 
cytoskeletal organization (Figure 3D-E).  Upregulation of cytoskeleton-associated 
networks in the SLE LDG proteome, alongside phosphoproteomic findings suggestive of 
differential cytoskeletal reorganization among neutrophil subsets, prompted investigation 
of neutrophil biomechanical properties. 
 
Neutrophil biomechanical properties are altered in clinically active SLE. 
 
RT-DC is a high-throughput technique that analyzes biomechanical properties of 
thousands of cells in suspension 36. An inverted microscope with a high-speed camera 
captures images of individual cells moving through a narrow constriction channel within 
a PDMS microfluidic chip, where cells are deformed by hydrodynamic shear stress. Cell 
tracing algorithms generate biomechanical profiles per cell, including cell size (cross-
sectional area), roughness (cell surface perturbations quantified by dividing the convex 
hull area by the cross-sectional area), and deformability (one minus the value of 
circularity within a constriction channel). Cell populations are identified in blood by size 
and brightness (Figure 4A) 37. These measurements were obtained in peripheral blood 
from HC (N=11), clinically quiescent (N=11) or clinically active SLE (N=4). In some 
experiments, fMLF was added directly to HC peripheral blood to prime neutrophils prior 
to analysis. Neutrophils from HC and clinically quiescent SLE were biomechanically 
identical, while active SLE neutrophils had larger areas, enhanced deformability and 
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roughness. FMLF-primed HC neutrophils were also larger and more deformable than 
unstimulated neutrophils and significantly rougher than any unstimulated neutrophil 
subsets (Figure 4B). Overall, neutrophils from active SLE subjects displayed altered 
biomechanical properties and cell membrane perturbations. 
 
SLE LDGs and NDNs are biomechanically distinct  
 
Biomechanical properties of purified SLE LDGs/NDNs from clinically quiescent 
subjects and HC NDNs were quantified, using optimized purification strategies to avoid 
disruption of biomechanical properties (Supplementary Figure 1). Gating strategies 
allowed for identification of neutrophils, monocytes, lymphocytes and eosinophils in 
mixed cell fractions (Figure 4A) 37. Biomechanical properties did not differ in lymphocytes 
and monocytes between SLE and HC subjects (Supplementary Figure 4).  In contrast, 
SLE LDGs displayed distinct biomechanical features relative to other neutrophil subsets 
(Figure 4E). While HC and SLE NDNs were round and smooth, SLE LDGs had 
significantly rougher cell surfaces that correlated with age but not with other 
clinical/demographic characteristics (Supplementary Figure 5). HC NDNs incubated for 
various time-points with Sm/RNP immune complexes 7 and/or recombinant IFN-α 
displayed no changes in neutrophil roughness (Supplementary Figure 6). Overall, SLE 
LDGs display distinct biomechanical properties seemingly unrelated to exposure to 
immune complexes or type I IFNs. 
 
Neutrophil percentages were higher in SLE than HC PBMC fractions (Figure 4C-D), 
consistent with higher LDG numbers 9. It is unclear whether LDGs are present in  small 
numbers in healthy individuals but expanded in SLE 38. We compared biomechanical 
properties of SLE LDGs to the small population of HC LDGs. Like autologous HC NDNs, 
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and not consistent with the SLE LDG biomechanical phenotype, HC LDGs displayed 
smooth, non-polarized surfaces. HC LDGs were also more deformable than HC NDNs 
(Figure 5C). These differences in biomechanical properties support SLE LDGs do not 
represent expansion of a minor LDG population found in HCs. 
 
While fMLF-primed HC NDNs are morphologically rougher 17 and localize to the PBMC 
interphase on density gradients (Figure 4D) 17, they were consistently larger than 
autologous unprimed NDNs. This contrasts with SLE LDGs, which were similar in size to 
autologous SLE NDNs (Figure 4E), supporting primed HC NDNs and SLE LDGs are 
biomechanically distinct. These biomechanical differences were confirmed by brightfield 
(Figure 4F-G) and lattice light-sheet fluorescence microscopy (Supplementary Figure 7). 
The cell surface of fMLF-primed HC NDNs appeared to ruffle, with small membrane 
perturbations moving inwards and outwards. In contrast, SLE LDGs’ cell surface was 
smooth, except for sections of dramatic protrusions, which were irregularly shaped 
(Figure 4F-G). This suggests SLE LDGs have distinct biophysical properties not 
consistent with acutely primed phenotypes.  
 
 
 
SLE LDGs are retained in a microfluidic microvasculature mimetic (MMM) 
 
Neutrophil biomechanical properties can modulate transit through the pulmonary 
microvasculature. Primed neutrophils are retained in pulmonary capillary beds 39, 
possibly due to enhanced cell stiffness and/or irregular cell shape 40. To mimic trafficking 
through the pulmonary microvasculature, we developed an MMM formed of a branched 
pyramidal network within a PDMS chip (Figure 5A). Neutrophils flowed through this 
network at physiologically relevant pressures (10 and 50mbar, or 10.2 and 51.0 cmH2O, 
respectively) 40 without impact on viability (Supplemental Figure 8). As previously 
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reported 39 40, fMLF-primed HC NDNs were increasingly retained in the MMM, with >80% 
unable to fully navigate it. In contrast, >80% unprimed HC NDNs navigated the MMM 
within three seconds. Trafficking patterns of SLE LDGs resembled those of primed HC 
NDNs, with >75% SLE LDGs retained in the MMM vs approximately 50% SLE NDNs 
(Figure 5B). Of neutrophils transiting the entire MMM, SLE and unprimed HC NDNs 
averaged a transit time of <0.9 seconds, while SLE LDGs and primed HC NDNs 
averaged transit times of 1.87 and 2.89 seconds, respectively (Figure 5C).  
 
HC NDNs treated with cytochalasin D, which disassembles filament actin and decreases 
neutrophil deformability 36, were increasingly retained in the  MMM (>75% retention vs. 
<20% in vehicle-treated HC NDNs (Figure 5D)), supporting biomechanical modulation 
alters neutrophil trafficking. Like primed HC NDNs 39, SLE LDGs may be preferentially 
retained in microvasculature due to biomechanical property differences.  
 
The MMM evaluated effects of cellular biomechanical properties on trafficking but not the 
putative role of neutrophil-endothelial interactions. By decoupling effects of biophysical 
properties and cell-surface markers on neutrophil trafficking, we evaluated their 
independent contributions. A two-dimensional assay evaluated neutrophil interactions-
rolling alongside or adherence to microvascular endothelium- in a circulatory flow system 
mimicking physiological conditions (flow rate 0.4 mL/min). Over three minutes, 15% and 
60% primed HC NDNs interacted with unstimulated or stimulated endothelium, 
respectively.  In contrast, <10% and <20% HC NDNs, SLE LDGs and NDNs interacted 
with unstimulated and stimulated endothelium, respectively (p<0.01 compared to primed 
HC NDNs and p>0.05 comparing other neutrophil subsets; Figure 5E-F; Supplementary 
Figure 9). These observations suggest that, while enhanced neutrophil-endothelium 
interactions may contribute to microvasculature retention of primed HC NDNs, they do 
not explain differences in microvasculature trafficking observed between SLE LDGs and 
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NDNs. Overall,  SLE LDGs may be retained in microvasculature networks 39, by intrinsic 
changes in cellular biomechanical properties rather than by specific neutrophil-
endothelium interactions.  
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Discussion 
 
We identified significant differences between the SLE and healthy control 
neutrophil proteomes as well as heterogeneity in the proteome of SLE neutrophils 
including proteins involved in formation/rearrangement of the cytoskeleton. In addition, 
we identified biomechanical differences in SLE LDGs with implications for neutrophil 
trafficking in the microvasculature. 
 
Consistent with the proteomics data and previous transcriptomic analyses reporting 
differential gene expression associated with the actin cytoskeleton in SLE LDGs 8, we 
found SLE LDGs are biomechanically distinct and showed cell membrane perturbations 
differing from fMLF-primed neutrophils 17 41. While mechanisms promoting enhanced 
SLE LDG cytoskeletal changes remain unclear, differential abundance of proteins 
associated with extracellular structure organization and cytolysis may be implicated. For 
example, PFN1 modulates actin/microtubule dynamics 30 42 and actin polymerization 43, 
while HRG induces neutrophil morphologic changes 29 implicated in neutrophil retention 
in microvasculature 29 44. Furthermore, the enhanced ability of LDGs to form NETs may 
contribute to cytoskeleton perturbations and disruptions in  cell membrane integrity 15 45-
47. Although SLE LDGs did not morphologically resemble HC neutrophils treated with 
Sm/RNP immune complexes or PMA to induce NETosis (Supplementary Figures 6, 7), 
differences in spontaneous LDG NET formation and PMA-induced NET formation have 
been reported 48 7 8. The potential link between NET formation, neutrophil proteome and 
biomechanical properties of LDGs should be studied further.  
 
Previous studies indicate rougher, primed neutrophils are retained in the lungs 29 40. Our 
MMM data suggests LDG roughness may similarly hinder LDGs’ ability to traffic through 
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narrow capillaries and biophysical properties, not enhanced binding to endothelium 40. 
Increased retention in microvasculature networks could have pathogenic implications in 
lung or kidney damage, and in development of small vessel vasculopathy. SLE lung 
manifestations are associated with blood vessel damage triggered by neutrophils 49-51. 
Circulating immune complexes can activate neutrophils, promote endothelial cell barrier 
dysfunction and perturbed vascular permeability 52 53. While distinct biomechanical 
properties of SLE LDGs did not align with preferential binding to microvascular 
endothelial cells, LDGs have potent deleterious effects on endothelium through NET 
formation 7 54 55. Accordingly, we propose a model where slow LDG microvasculature 
transit, coupled to enhanced NETosis, promotes vasculopathy. Future studies should 
assess mechanisms of enhanced SLE LDG roughness and in vivo significance of its 
effect on LDG trafficking.  
 
In contrast to SLE LDGs, fMLF-primed NDNs showed enhanced adherence to 
endothelium and higher abundance of phosphoproteins linked to cell adhesion 56-59. 
Actin-regulatory proteins are de-phosphorylated in LDGs but phosphorylated in primed 
neutrophils, suggesting both actin depolymerization and polymerization may induce 
biophysical changes affecting trafficking. Indeed, imaging showed primed NDNs with 
contracted cortical actin rings while LDGs appeared irregularly shaped with incomplete 
actin rings (Supplementary Figure 7, Movies 1-4). Overall, SLE LDGs differ from acutely 
primed neutrophils and interact with the vasculature differently. 
 
The type I IFN pathway is linked to SLE pathogenesis and neutrophils responding to 
these cytokines exhibit proinflammatory responses 4. ISG-encoded proteins were higher 
in SLE LDGs, consistent with transcriptome reports 16. Why SLE LDGs express higher 
ISG-encoded proteins than autologous SLE NDNs, exposed to similar levels of cytokines 
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in vivo, could be related to differences in JAK-STAT activity or to differences in activation 
status 16. SLE LDGs have enhanced ISG hypomethylation relative to HC neutrophils, 
perhaps modulating the protein response 60. Future studies should address how 
enhanced IFN responses modulate pathogenic differences linked to LDGs’ ability to NET 
and damage vasculature.  
 
The SLE LDG proteome contained increased acute phase response proteins associated 
with complement and coagulation 61. Corroborating our findings, LDGs display 
significantly enhanced transcription of several complement components (Supplementary 
Figure 3). Some complement proteins identified by proteomics were not identified by 
transcriptomics. These proteins, including C6-C9, may bind to circulating neutrophils. 
This aligns with findings of C6-C9 contributing to formation of MAC-induced lytic pores in 
rheumatoid arthritis neutrophils62. Additionally, activated HC NDNs upregulate C3 
transcription (Supplementary Figure 10), suggesting activated LDGs may behave in a 
similar manner. This LDG-complement relationship should be investigated further. 
 
Some proteins associated to platelet biology were more abundant in SLE LDGs, similar 
to descriptions in psoriasis LDGs63. This was confirmed by fluorescence microscopy 
(Supplementary Figure 1) and suggests commonalities in the proteome of LDGs across 
inflammatory diseases associated with enhanced vascular damage. Platelet-neutrophil 
interactions can drive inflammation and thrombosis 64; thus, increased platelet presence 
in LDG samples may contribute to  their upregulation of coagulation and  some 
neutrophil activation-associated proteins relative to NDNs. Ultimately, LDG-platelet 
interactions may play distinct pathophysiologic roles in vasculopathy development.  
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Alongside the proteomics, the biomechanical profile and trafficking pattern of SLE LDGs 
support reports that LDGs represent a distinct neutrophil subset rather than expansion of 
immature/primed neutrophils present in healthy subjects 15 65 66.  SLE LDGs have a 
distinct proteomic signature and specific biomechanical features impacting transit 
through the microvasculature. This study adds to the understanding of neutrophil 
heterogeneity in the context of blood vessel trafficking, with important implications for 
development of small vessel vasculopathy and organ damage and development of 
therapeutics modulating neutrophil biomechanical properties 67.   
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Key messages:   
 
 What is already known about this subject? Low density granulocytes (LDGs) are 
a subset  of neutrophils  expanded in SLE. These cells have been shown to have 
a pathogenic role through their enhanced ability to form neutrophil extracellular 
traps, promote type I IFN responses and damage the vasculature. Their levels  
and gene signature associate with enhanced vasculopathy and atherosclerosis in 
lupus patients. 
 What does this study add? The findings from this study indicate that lupus LDGs 
display distinct proteomic and biomechanical properties that may impact their 
ability to travel through the vasculature,  interact with the endothelium and 
enhance their trapping in the small vessels of various organs. 
 How might this impact on clinical practice? Increased retention of lupus LDGs  in 
microvasculature could have pathogenic implications in lung or kidney damage, 
and in development of small vessel vasculopathy. These results suggest that 
development of therapeutics modulating neutrophil biomechanical properties 
could modulate deleterious responses in lupus and other autoimmune diseases. 
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Figure Legends 
 
Figure 1.  SLE NDNs differ in their proteome and phosphoproteome compared to 
HC NDNs. (A & B) A total of 4109 proteins (A) and 875 phosphoproteins (B) were 
identified by mass spectrometry in LDGs and NDNs from SLE subjects (n=5) and 
unstimulated and primed NDNs from HC volunteers (n=5). Volcano plots depict 
differences between SLE NDN and LDG proteomes (C) and phosphoproteomes (D). The 
upregulated (red) and downregulated (green) proteomes are in LDGs, while NDNs are 
the reference proteome. (E) Gene ontology biological process analysis highlighting 
biological networks associated with proteins more abundant in at least 4/5 SLE NDN 
samples relative to HC NDNs. Proteins with abundance ratios greater than 1.5 were 
included and significance was established by false discovery rate (FDR).  (F) Proteins 
responsible for upregulation of networks associated with neutrophil activation in SLE 
NDNs relative to HC NDNs in arbitrary units. Significance was established by Kruskal-
Wallis test with post hoc Dunn’s tests for multiple comparisons (3 comparisons) or by 
Mann-Whitney U test (2 comparisons). (G) Relative abundance of IFN inducible proteins 
in SLE NDNs and HC NDNs relative to SLE LDGs. SLE NDNs were compared to 
autologous SLE LDGs. HC NDNs were compared to the mean protein abundance in 
SLE LDGs.  Open boxes in heatmaps indicate the given protein was not identified in the 
sample. (H) Abundance of cell integrins and adhesion-related proteins in SLE NDNs and 
HC NDNs relative to autologous SLE LDGs and autologous primed HC NDNs 
respectively. (I) Abundance of phosphoproteins associated with regulation of neutrophil-
endothelial interactions in all neutrophil subsets, in arbitrary units. Significance was 
established by Kruskal-Wallis test with post hoc Dunn’s tests for multiple comparisons. 
All results are mean ± SEM and significance was set at *p ≤ 0.05, **p≤ 0.01, ns=not 
significant. 
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Figure 2. SLE LDGs have a distinct proteomic profile characterized by enhanced 
pathways associated to translational activity, intracellular trafficking and type I 
IFN-induced protein pathways. (A) Gene ontology biological process analysis 
highlighting biological networks associated with proteins less abundant in SLE LDGs 
(n=5) relative to SLE NDNs (n=5). Proteins with abundance ratios less than 0.5 in at 
least 4/5 matched samples were included and significance was established by false 
discovery rate (FDR).  (B) Relative abundance of degranulation network-associated 
proteins in SLE NDNs and HC NDNs relative to SLE LDGs. SLE NDNs were compared 
to autologous SLE LDGs. HC NDNs were compared to the mean protein abundance in 
SLE LDGs.  (C) Gene ontology biological process analysis highlighting biological 
networks associated with proteins more abundant in at least 4/5 SLE LDG samples 
relative to SLE NDNs. Proteins with abundance ratios greater than 1.5 were included 
and significance was established by false discovery rate (FDR). (D) Relative abundance 
of SLE network-associated proteins in SLE NDNs and HC NDNs relative to SLE LDGs. 
SLE NDNs were compared to autologous SLE LDGs. HC NDNs were compared to the 
mean protein abundance in SLE LDGs. (E) Relative abundance of eukaryotic translation 
network-associated proteins in SLE NDNs and HC NDNs relative to SLE LDGs. SLE 
NDNs were compared to autologous SLE LDGs. HC NDNs were compared to the mean 
protein abundance in SLE LDGs. Open boxes in heatmaps indicate the given protein 
was not identified in the sample. (F) Relative abundance of coagulation and platelet 
network-associated proteins in SLE NDNs and HC NDNs relative to SLE LDGs. SLE 
NDNs were compared to autologous SLE LDGs. HC NDNs were compared to the mean 
protein abundance in SLE LDGs. (G) Gene ontology biological process analysis 
highlighting biological networks associated with phosphoproteins differentially abundant 
in SLE LDGs and NDNs. Phosphoproteins with abundance ratios less than 0.5 or 
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greater than 1.5 in at least 4/5 matched samples were included and significance was 
established by false discovery rate (FDR). (H) Abundance of transcription factors 
CEBPD and SPI1 in arbitrary units. CEBPD not identified in HC NDNs. Results are 
mean ± SEM, with comparisons between autologous SLE LDG and NDNs. Significance 
established by Kruskal-Wallis test with post hoc Dunn’s tests for multiple comparisons  
and set at *p ≤ 0.05, ns=not significant. N.F. = not found. 
 
Figure 3. Proteomic and phosphoproteomic analyses indicate differential 
expression of proteins associated to cytoskeleton function between SLE NDNs 
and LDGs. (A) Gene ontology biological process analysis highlighting biological 
networks related to the cytoskeleton and associated with proteins more abundant in at 
least 4/5 SLE LDG samples relative to their matched SLE NDNs. Proteins with 
abundance ratios greater than 1.5 were included and significance was established by 
false discovery rate (FDR).  (B) Abundance of cytoskeleton-associated proteins in SLE 
NDNs and HC NDNs relative to SLE LDGs. SLE NDNs were compared to autologous 
SLE LDGs. HC NDNs were compared to the mean protein abundance in SLE LDGs. 
Open boxes in heatmaps indicate the given protein was not identified in one of the two 
autologous samples being compared. (C) Abundance of cytoskeleton network-
associated phosphoproteins in SLE LDGs relative to abundance in autologous SLE 
NDNs. (D) Gene ontology biological process analysis highlighting biological networks 
associated with phosphoproteins differentially abundant in primed HC NDNs (n=5) and 
unstimulated HC NDNs (n=5). Proteins with abundance ratios greater than 1.5 or less 
than 0.5 in at least 4/5 matched samples were included and significance was established 
by false discovery rate (FDR). (E) Abundance of phosphoproteins regulating the 
cytoskeleton in primed HC NDNs relative to autologous HC NDNs. 
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Figure 4.  SLE LDGs are biomechanically rougher than other neutrophil subsets 
by real-time deformability cytometry. (A) RT-DC was used to biomechanically 
characterize the shape, size, and deformability of neutrophil subsets. (B) Biomechanical 
profiling of neutrophils in blood samples obtained from healthy volunteers (n=12), 
clinically quiescent SLE patients (n=9), and active SLE patients (n=4) by RT-DC. In 
some instances, 100nM fMLF was used to prime neutrophils within the healthy blood. 
(C) Percentage of LDGs identified in SLE (n=6) and HC PBMCs (n=6) by RT-DC. (D) 
LDGs as a percentage of total neutrophils in SLE patients (n=6), HC volunteers (n=6), 
and fMLF-primed HC blood (n=6). (E) Biomechanical profiling of isolated NDNs and 
LDGs from HC volunteers (n=11) and clinically quiescent SLE patients (n=11) by RT-
DC. Some HC NDNs were primed with fMLF prior to isolation. For each sample 
analyzed by RT-DC, the median measurement of over 500 neutrophils is graphed and 
the mean ± SEM for each neutrophil subset is depicted. Autologous unstimulated/primed 
HC NDNs or autologous SLE NDN/LDGs were compared and significance was 
established by Wilcoxon matched-pairs signed rank tests. In other comparisons, 
significance was established by Mann-Whitney U-tests. Significance was set at *p ≤ 
0.05, **p≤ 0.01, ns=not significant. (F) Images of NDNs and LDGs captured during RT-
DC, representative of >500 images of each neutrophil subset from n=11 SLE patients 
and n=11 HC volunteers, 10x objective. White arrows identify a concave cell surface 
feature common in primed HC NDNs and an irregular protrusion in the cell surface 
common in SLE LDGs. (G) Brightfield microscopy of NDNs and LDGs (n=3). White 
arrows identify rounded, protruded, membrane features observed in nearly 100% of 
primed HC NDNs and an irregular protrusion observed in ~30% of SLE LDGs. See 
supplementary movie files. 
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Figure 5.  SLE LDGs are increasingly retained within a three-dimensional 
pulmonary microvasculature mimetic, but do not display enhanced adherence to 
endothelial cells in a two-dimensional system of flow. (A) A branching microfluidic 
mimetic of the pulmonary microvasculature was designed. Arrows indicate the inlet, 
outlet, and a cell navigating the network, 10x objective. (B) Retention of NDNs and LDGs 
in the microvasculature mimetic (n>150 neutrophils per subset from n=6 HC volunteers 
and n=6 SLE patients). Seconds until release refers to the amount of time each 
neutrophil was retained within the mimetic, measured from entry at the inlet to exit at an 
outlet. Seconds until release was recorded as >120 seconds if cells did not exit the 
mimetic within the two-minute video. Times were determined manually with a timer 
superimposed on the video during data collection. Significance was determined by log-
rank test. (C) Transit times through the microvasculature mimetic for all NDNs and LDGs 
navigating the entire device. Significance assessed by Mann-Whitney U-test. (D) 
Retention of HC NDNs treated with DMSO or cytochalasin D in the microvasculature 
mimetic (n>50 neutrophils from n=3 HC volunteers). Significance was determined by log-
rank test. (E) Percentage of neutrophils interacting with endothelium under 0.4mL/min 
flow. Significance was determined by Kruskal-Wallis test with post hoc Dunn’s tests for 
multiple comparisons.  (F) Light microscopy of neutrophil binding to endothelium post-
flow assay. Arrows show enhanced binding of primed NDNs. Images representative of 
n=4 images obtained for each neutrophil subset isolated from n=6 SLE patients or n=6 
HC volunteers. All results are mean ± SEM with significance was set at *p ≤ 0.05, **p≤ 
0.01, ****p≤ 0.0001, ns=not significant. 
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